and simultaneously began medical school at Stanford University. He subsequently completed a medical residency and subspecialty training at UCSF before joining the full-time research faculty in 1988.
Dr. Cohen's research interests center around computational models for protein folding, structure, and function. Applications of this work have led to advances in drug design and discovery with a particular emphasis on parasitic disease. More recent work has attempted to understand the structural underpinnings of the neurodegenerative diseases caused by prions. Dr. Cohen has received a Searle Scholars Award, the Richard E. Weitzmann Young Investigator Award from the Endocrine Society, and the Young Investigator Award of the Western Society of Clinical Investigation. Dr. Cohen serves on the Molecular and Cellular Biophysics Study Section of the National Institutes of Health, as an editor of the Journal of Molecular Biology, and as a member of the editorial boards of Protein Engineering, Perspectives in Drug Discovery and Design, Computational Biology, and Molecular Medicine.
Eric S. Lander
Director, Whitehead Institute for Biomedical Research and
Professor, Massachusetts Institute of Technology
Dr. Lander is a member of the Whitehead Institute for Biomedical Research, director of the Center for Genome Research, and professor of biology at the Massachusetts Institute of Technology. His background includes both pure mathematics and laboratory molecular genetics. He also taught managerial economics at the Harvard Business School from 1981 to 1989. Early in this period, he became interested in biology and acquired laboratory training in fruit fly, nematode, and human genetics.
Dr. Lander's theoretical work includes the development of mathematical methods for the genetic dissection of complex inherited traits; algorithms for genetic mapping; analytical approaches to physical map construction; and population genetic methods for finding human disease genes. His laboratory work includes the construction of genetic linkage maps of the mouse and rat genomes; construction of physical maps of the human genome; genetic dissection of traits, including colon cancer susceptibility in the mouse and diabetes susceptibility in the rat;